Theravance Biopharma Earnings Preview
Portfolio Pulse from Benzinga Insights
Theravance Biopharma (NASDAQ:TBPH) is set to release its quarterly earnings report on Monday, 2023-08-07. Analysts estimate an earnings per share (EPS) of $-0.16. The company's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. The stock is currently trading at $9.92 and has seen a 13.31% increase over the last 52-week period.
August 04, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Theravance Biopharma is expected to report an EPS of $-0.16. The company has a history of beating EPS estimates, which has generally led to an increase in share price. The stock has seen a 13.31% increase over the last 52-week period.
Theravance Biopharma has a history of beating EPS estimates, which has generally led to an increase in share price. Given this trend and the positive 52-week performance, the upcoming earnings report could potentially have a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100